Managers / Q4 2022 · view latest →
BEDRIJFSTAKPENSIOENFONDS VOOR DE MEDIA PNO
CIK 0001274196 · POSTBUS 1340, HILVERSUM, P7, 1200 BH · 0031356259261
Summary
Bedrijfstakpensioenfonds Voor De Media Pno reported $510M in U.S.-listed holdings across 41 positions for Q4 2022.
Its largest position, AAPL, represents 7.5% of the portfolio.
Compared with Q3 2022, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.8% · $504M
- REIT · 1.2% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DXCMDEXCOM INC | NEW | +66.0K | 66.0K | +$7M | $7M |
| ILMNILLUMINA INC | ADDED | +16.0K | 48.7K | +$3M | $9M |
| EWEDWARDS LIFESCIENCES CORP | ADDED | +33.0K | 158.0K | +$503,000 | $11M |
| LLYELI LILLY & CO | TRIMMED | −11.0K | 42.1K | −$3M | $14M |
| SNPSSYNOPSYS | TRIMMED | −5.0K | 19.5K | −$2M | $6M |
| EQIXEQUINIX INC | TRIMMED | −2.5K | 10.1K | −$1M | $6M |
| MRSHMARSH & MCLENNAN COS | TRIMMED | −8.0K | 34.0K | −$1M | $5M |
| LOWLOWE'S COS | TRIMMED | −8.0K | 37.0K | −$2M | $7M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $759M | 39 | Oct 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $724M | 39 | Jul 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $703M | 40 | Apr 16, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $802M | 40 | Jan 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $773M | 41 | Oct 21, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $781M | 41 | Jul 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $760M | 40 | Apr 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $675M | 40 | Jan 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $622M | 40 | Oct 30, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $646M | 40 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $599M | 40 | Apr 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $510M | 41 | Jan 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $556M | 40 | Oct 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $594M | 39 | Jul 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $778M | 39 | Apr 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $910M | 38 | Jan 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $839M | 38 | Oct 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $844M | 38 | Jul 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $803M | 39 | Apr 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $716M | 36 | Feb 4, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $678M | 36 | Oct 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $639M | 35 | Jul 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $532M | 35 | Apr 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $601M | 35 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $584M | 36 | Dec 11, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2019 | $634M | 35 | Jul 16, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $605M | 35 | Apr 25, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.